Clinical trial
Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease
NCT03801642 is registered in ClinicalTrials.gov with Jeff Burns, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease
- Lead sponsor
- Jeff Burns, MD
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 29, 2019
- Completion date
- July 7, 2022
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.